Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01265849|
Recruitment Status : Active, not recruiting
First Posted : December 23, 2010
Last Update Posted : March 19, 2021
Teva Branded Pharmaceutical Products R&D, Inc.
Orient Europharma Co., Ltd.
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Active, not recruiting|
|Actual Primary Completion Date :||May 15, 2020|
|Estimated Study Completion Date :||April 15, 2021|